Calcium channel blockers or beta receptor antagonists for patients with ischaemic heart disease. What is the best choice?
Rydén
L
L
Malmberg
K
K
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use*; D016022:Case-Control Studies; D003327:Coronary Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D004359:Drug Therapy, Combination; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers